A study of factors impacting disease based on the Charlson Comorbidity Index in UK Biobank
ObjectiveWith advances in medical diagnosis, more people are diagnosed with more than one disease. The damage caused by different diseases varies, so relying solely on the number of diseases to represent multimorbidity is limited. The Charlson comorbidity index (CCI) is widely used to measure multim...
Main Authors: | Changcong Wang, Xinyue Zhang, Bai Li, Dongmei Mu |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-01-01
|
Series: | Frontiers in Public Health |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fpubh.2022.1050129/full |
Similar Items
-
Niacin, lutein and zeaxanthin and physical activity have an impact on Charlson comorbidity index using zero-inflated negative binomial regression model: National Health and Nutrition Examination Survey 2013–2014
by: Hantong Zhao, et al.
Published: (2019-11-01) -
Comorbidity in limited disease small-cell lung cancer: Age-adjusted Charlson comorbidity index and its association with overall survival following chemoradiotherapy
by: Christoph A. Fink, et al.
Published: (2023-09-01) -
Study on influencing factors of age-adjusted Charlson comorbidity index in patients with Alzheimer's disease based on machine learning model
by: Jian Ding, et al.
Published: (2025-01-01) -
Age-adjusted Charlson comorbidity index is associated with the risk of osteoporosis in older fall-prone men: a retrospective cohort study
by: Zi-Mo Pan, et al.
Published: (2024-05-01) -
Charlson comorbidity index in predicting deaths in COVID-19 patients
by: A. V. Svarovskaya, et al.
Published: (2022-04-01)